FindMyRecallSubscribe
Class I: serious health riskTerminated

Darmerica Quinacrine Dihydrochloride Recall

Quinacrine Dihydrochloride (98

Darmerica, LLC · Casselberry, FL

Risk level
Class I
Reported by FDA
Oct 2, 2019
Recall ID
D-0125-2020
Check your lot numberHow we source this data

Summary

Darmerica recalled Quinacrine Dihydrochloride starting Sep 6, 2019. The FDA classified it as Class I (serious health risk) and published enforcement report D-0125-2020 on Oct 2, 2019. Reason: Label Mix-Up: Product labeled as Quinacrine Dihydrochloride; however, after testing, identified as Artemisinin. Status: Terminated.

Why it was recalled

Label Mix-Up: Product labeled as Quinacrine Dihydrochloride; however, after testing, identified as Artemisinin.

Product description

Quinacrine Dihydrochloride (98.25%), bulk API product, packaged in a) 500 g NDC# 71052-530-05; b) 50 g NDC# 71052-530-55, c) 25g NDC# 71052-530-25, Darmerica LLC 198 Wilshire Blvd Casselberry, FL 32707

Lot numbers, UPCs & expiration codes

Lot#: a) DL4654A, Exp. 04/27/21; b) DR4654, Exp. 04/27/21 c) DR4654, Exp. 04/27/21

Where it was sold

U.S.A. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0125-2020
Classification
Class I
Status
Terminated
Recall initiated
Sep 6, 2019
FDA report date
Oct 2, 2019
Quantity
1.8 kilograms
Recall type
Voluntary: Firm initiated
Recalling firm
Darmerica, LLC

Original FDA data

Every field from FDA enforcement report D-0125-2020, exactly as published.

Show all FDA fields
City
Casselberry
State
FL
Status
Terminated
Country
United States
Event ID
83734
Address
198 Wilshire Blvd
Code information
Lot#: a) DL4654A, Exp. 04/27/21; b) DR4654, Exp. 04/27/21 c) DR4654, Exp. 04/27/21
Postal code
32707-5352
Report date
Oct 2, 2019
Product type
Drugs
Recall number
D-0125-2020
Classification
Class I
Recalling firm
Darmerica, LLC
Product quantity
1.8 kilograms
Termination date
Feb 5, 2021
Reason for recall
Label Mix-Up: Product labeled as Quinacrine Dihydrochloride; however, after testing, identified as Artemisinin.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Quinacrine Dihydrochloride (98.25%), bulk API product, packaged in a) 500 g NDC# 71052-530-05; b) 50 g NDC# 71052-530-55, c) 25g NDC# 71052-530-25, Darmerica LLC 198 Wilshire Blvd Casselberry, FL 32707
Distribution pattern
U.S.A. Nationwide
Recall initiation date
Sep 6, 2019
Initial firm notification
Letter
Center classification date
Oct 3, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0125-2020, published Oct 2, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls